We are live on
!
Find out more
Axa Portfolio holdings
AUM
$256M
1-Year Est. Return
25.01%
This Fund
S&P 500
This Quarter
Est. Return
+16.76%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$25.6B
AUM Growth
+$2.65B
(+12%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
14.38%
Holding
1,445
New
151
Increased
481
Reduced
509
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$56.6M |
| 2 |
Fidelity National Information Services
FIS
|
+$53M |
| 3 |
Advanced Micro Devices
AMD
|
+$48.1M |
| 4 |
RTX Corp
RTX
|
+$43.3M |
| 5 |
Analog Devices
ADI
|
+$38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$72.1M |
| 2 |
PepsiCo
PEP
|
+$70.8M |
| 3 |
American Express
AXP
|
+$70.7M |
| 4 |
Automatic Data Processing
ADP
|
+$49.7M |
| 5 |
Synchrony
SYF
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.3% |
| 2 | Healthcare | 15.12% |
| 3 | Consumer Discretionary | 10% |
| 4 | Financials | 9.68% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Regeneron Pharmaceuticals
REGN
$72.9B
| $29.6M | 0.12% |
72,157
+1,375
| +2% | +$566K |
|
227
BioMarin Pharmaceuticals
BMRN
$11.9B
| $29.5M | 0.12% |
332,427
-32,750
| -9% | -$3.04M |
|
228
O'Reilly Automotive
ORLY
$75.1B
| $29.3M | 0.11% |
1,133,475
+9,615
| +0.9% | +$233K |
|
229
Sempra
SRE
$58.1B
| $28.9M | 0.11% |
459,606
-1,394
| -0.3% | -$82.1K |
|
230
Loews
L
$24.5B
| $28.3M | 0.11% |
589,546
-181,590
| -24% | -$8.57M |
|
231
Jazz Pharmaceuticals
JAZZ
$16.1B
| $28.2M | 0.11% |
196,957
+10,703
| +6% | +$1.4M |
|
232
American Water Works
AWK
$27B
| $28M | 0.11% |
268,490
+5,345
| +2% | +$524K |
|
|
WBA
233
DELISTED
Walgreens Boots Alliance
WBA
| $27.9M | 0.11% |
440,322
+29,724
| +7% | +$2.03M |
|
234
Royal Caribbean
RCL
$86.8B
| $27.4M | 0.11% |
239,051
-20,842
| -8% | -$2.37M |
|
235
CVS Health
CVS
$135B
| $27.2M | 0.11% |
504,713
-93,819
| -16% | -$5.79M |
|
236
ConocoPhillips
COP
$144B
| $27.2M | 0.11% |
407,462
-168,237
| -29% | -$11.3M |
|
|
STOR
237
DELISTED
STORE Capital Corporation
STOR
| $27.2M | 0.11% |
810,696
+285,522
| +54% | +$9M |
|
238
Nike
NKE
$64.1B
| $26.9M | 0.11% |
319,408
-14,290
| -4% | -$1.18M |
|
239
CenterPoint Energy
CNP
$28.3B
| $26.8M | 0.1% |
872,525
+220,241
| +34% | +$6.66M |
|
240
Xylem
XYL
$28.5B
| $26.3M | 0.1% |
332,218
+64,440
| +24% | +$4.7M |
|
241
TAL Education Group
TAL
$6.04B
| $26.2M | 0.1% |
725,422
+47,382
| +7% | +$1.54M |
|
242
Electronic Arts
EA
$52.4B
| $25.9M | 0.1% |
255,044
+26,785
| +12% | +$2.54M |
|
|
GAP
243
The Gap Inc
GAP
$7.3B
| $25.9M | 0.1% |
988,700
+357,738
| +57% | +$9.14M |
|
244
Tesla
TSLA
$1.18T
| $25.6M | 0.1% |
1,374,540
-28,005
| -2% | -$562K |
|
|
DATA
245
DELISTED
Tableau Software, Inc.
DATA
| $25.5M | 0.1% |
200,148
+433
| +0.2% | +$54.7K |
|
246
PagSeguro Digital
PAGS
$2.67B
| $25.3M | 0.1% |
846,023
-19,890
| -2% | -$496K |
|
247
Cigna
CI
$78.4B
| $25.2M | 0.1% |
156,536
-53,054
| -25% | -$9.69M |
|
248
Zimmer Biomet
ZBH
$18.8B
| $24.9M | 0.1% |
201,109
+90,679
| +82% | +$10.3M |
|
249
Eversource Energy
ES
$28.1B
| $24.9M | 0.1% |
350,627
-40,932
| -10% | -$2.82M |
|
250
State Street
STT
$48.4B
| $24.9M | 0.1% |
377,883
+259,437
| +219% | +$18M |
|
Similar funds
PHAM
HFRG
EBWM
GCCM
CIA
KAM
ACM
CCA
Axa's Q1 2019 Portfolio in Review
As of Q1 2019, Axa held 1,445 positions worth $25.6B, up 12% from $22.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa withdrew a net $1.17B in Q1 2019, closing 137 positions and reducing 509 holdings. Its most notable exit was Newfield Exploration, an estimated $15.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Axa opened a new position in BlackBerry worth $40.1M.
- Axa's largest Q1 2019 buy was BlackBerry: 3,971,844 shares worth $40.1M.
- Axa added most to Gilead Sciences in Q1 2019, an estimated $56.6M increase.
- Axa's biggest Q1 2019 reduction was Humana, cutting an estimated $72.1M.
- Axa fully exited Newfield Exploration in Q1 2019, selling an estimated $15.3M.
- Axa's ten largest holdings make up 14% of its $25.6B portfolio in Q1 2019.
- Axa opened 151 new positions and closed 137 in Q1 2019.
- Axa's portfolio value rose 12% quarter-over-quarter to $25.6B.
Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.